Myocardial Minimal Damage After Rapid Ventricular Pacing – the prospective randomized multicentre MyDate-Trial

[1]  F. Morady,et al.  Significance of clinical ventricular tachycardias induced by antitachycardia pacing in patients with prior myocardial infarction. , 2019, Heart rhythm.

[2]  M. Karch,et al.  Pacemaker Implantation Associated Myocardial Micro-Damage: A Randomised Comparison between Active and Passive Fixation Leads , 2018, Scientific Reports.

[3]  Allison T. Connolly,et al.  Association of Antitachycardia Pacing or Shocks With Survival in 69,000 Patients With an Implantable Defibrillator , 2017, Journal of cardiovascular electrophysiology.

[4]  P. Soler-Palacín,et al.  Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients , 2016, Medicine.

[5]  G. Boriani,et al.  Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: Efficacy, safety, and impact on mortality. , 2016, Heart rhythm.

[6]  James R. Johnson,et al.  Effect of ICD Therapies on Mortality in the OMNI Trial , 2016, Journal of cardiovascular electrophysiology.

[7]  J. Healey,et al.  Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial. , 2016, Heart rhythm.

[8]  B. Zrenner,et al.  ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing—The Prospective, Randomized, Multicentre TropShock-Trial , 2015, PloS one.

[9]  A. García-Alberola,et al.  Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study , 2015, Journal of cardiovascular electrophysiology.

[10]  S. Sears,et al.  Examination of the differential impacts of antitachycardia pacing vs. shock on patient activity in the EMPIRIC study. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  R. Zahn,et al.  Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  A. Rebuzzi,et al.  The Association Between ICD Interventions and Mortality is Independent of their Modality: Clinical Implications , 2014, Journal of cardiovascular electrophysiology.

[13]  H. Nathoe,et al.  Myocardial Injury After Noncardiac Surgery and its Association With Short-Term Mortality , 2013, Circulation.

[14]  A. Moss,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[15]  J. Sellal,et al.  Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: a prospective study. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  M. Raitt,et al.  Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. , 2011, Heart rhythm.

[17]  G. Andrikopoulos,et al.  Tachycardia induction due to inappropriate implantable cardioverter defibrillator therapy: what is the mechanism? , 2010, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[18]  B. Wilkoff,et al.  Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. , 2010, Heart rhythm.

[19]  I. Mahé,et al.  A Prospective Study , 2009 .

[20]  M. Zahid,et al.  Detectable Troponin Levels Predict Poor Prognosis in Patients With Left Ventricular Dysfunction Undergoing Internal Defibrillator Implantation , 2007, Pacing and clinical electrophysiology : PACE.

[21]  Zengri J. Wang,et al.  A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. , 2006, Journal of the American College of Cardiology.

[22]  A. Jeremias,et al.  Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded , 2005, Annals of Internal Medicine.

[23]  R. Canby,et al.  Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.

[24]  Michael O. Sweeney,et al.  Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease , 2001, Circulation.

[25]  A. Schaumann,et al.  Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. , 1998, Circulation.

[26]  M. Rosenqvist,et al.  Myocardial injury after electrical therapy for cardiac arrhythmias assessed by troponin-T release. , 1997, The American journal of cardiology.

[27]  A. Moss,et al.  Mortality Reduction In Relation To ICD Programming In MADIT-RIT , 2014 .

[28]  Gordon L. Shaw.  Clinical implications , 2004, European Journal of Pediatrics.